An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression of Alzheimer’s disease in closely watched trials.
Semaglutide fails to slow progression of Alzheimer’s in highly anticipated trials, Novo Nordisk says
Related Posts
-
Woman charged after allegedly shooting car with fiancé and child inside
A man told officers his fiance fired a gun at him and their child after…
-
Trail Blazers head coach Chauncey Billups pleads not guilty to crimes stemming from alleged poker scheme
Portland Trail Blazers head coach Chauncey Billups pleaded not guilty to charges stemming from a…
-
Iowa farmers have 120 days to file indemnity claims after Nebraska grain dealer announces bankruptcy
The Iowa Department of Agriculture and Land Stewardship said farmers have 120 days to file…
-
Caitlin Clark to make USA Basketball national team camp debut
Caitlin Clark will make her USA Basketball national team camp debut when the Americans get…
Leave a Reply